دورية أكاديمية
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research to advance the health of people with inherited bleeding disorders with the potential to menstruate.
| العنوان: | Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research to advance the health of people with inherited bleeding disorders with the potential to menstruate. |
|---|---|
| المؤلفون: | Baldwin MK; Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon, USA., Ahmadzia HK; Department of Obstetrics and Gynecology, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA., Bartlett DL; The Hemophilia Center, St Luke's Hemophilia Center, Boise, Idaho, USA., Bensen-Kennedy D; CSL Behring, King of Prussia, Pennsylvania, USA., Desai V; CSL Behring, King of Prussia, Pennsylvania, USA., Haley KM; The Hemophilia Center, Oregon Health and Science University, Portland, Oregon, USA.; Department of Pediatrics, Oregon Health and Science University, Portland, Oregon, USA., Herman-Hilker SL; Hemophilia and Coagulation Disorders Program, University of Michigan, Ann Arbor, Michigan, USA., Kilgore AM; Bleeding and Clotting Disorders Institute, Peoria, Illinois, USA., Kulkarni R; MSU Center of Bleeding and Clotting Disorders, Department Pediatrics and Human Development, Michigan State University, East Lansing, Michigan, USA., Lavin M; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.; National Coagulation Centre, St. James's Hospital, Dublin, Ireland., Luckey S; Hemophilia Foundation of Michigan, Ypsilanti, Michigan, USA., Matteson KA; Department of Obstetrics and Gynecology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA., Paulyson-Nuñez K; Duke Health Women & Children's Services, Duke University Health Systems, Durham, North Carolina, USA., Philipp CS; Division of Hematology, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA., Ragosta S; Ibis Reproductive Health, Oakland, California, USA., Rosen K; Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, USA., Rotellini D; National Hemophilia Foundation, New York, New York, USA., Weyand AC; Division of Pediatric Hematology and Oncology, University of Michigan Medical School, Ann Arbor, Michigan, USA. |
| المصدر: | Expert review of hematology [Expert Rev Hematol] 2023 Mar; Vol. 16 (sup1), pp. 71-86. |
| نوع المنشور: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101485942 Publication Model: Print Cited Medium: Internet ISSN: 1747-4094 (Electronic) Linking ISSN: 17474094 NLM ISO Abbreviation: Expert Rev Hematol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2015- : Abingdon, Oxford : Taylor & Francis Original Publication: London : Expert Reviews |
| مواضيع طبية MeSH: | Hematologic Diseases* , Menstruation*, Female ; Humans ; Pregnancy ; United States |
| مستخلص: | Background: People who have or had the potential to menstruate (PPM) with inherited bleeding disorders (BD) face particular challenges receiving appropriate diagnosis and care and participating in research. As part of an initiative to create a National Research Blueprint for future decades of research, the National Hemophilia Foundation (NHF) and American Thrombosis and Hemostasis Network conducted extensive all-stakeholder consultations to identify the priorities of PPM with inherited BDs and those who care for them. Research Design and Methods: Working group (WG) 4 of the NHF State of the Science Research Summit distilled community-identified priorities for PPM with inherited BDs into concrete research questions and scored their feasibility, impact, and risk. Results: WG4 identified important gaps in the foundational knowledge upon which to base optimal diagnosis and care for PPM with inherited BDs. They defined 44 top-priority research questions concerning lifespan sex biology, pregnancy and the post-partum context, uterine physiology and bleeding, bone and joint health, health care delivery, and patient-reported outcomes and quality-of-life. Conclusions: The needs of PPM will best be advanced with research designed across the spectrum of sex and gender biology, with methodologies and outcome measures tailored to this population, involving them throughout. |
| References: | Thromb Haemost. 2012 Jan;107(1):22-9. (PMID: 22159564) Haemophilia. 2022 May;28 Suppl 4:18-25. (PMID: 35521724) Expert Rev Hematol. 2023 Mar;16(sup1):87-106. (PMID: 36920863) Am J Obstet Gynecol. 2012 Oct;207(4):269.e1-5. (PMID: 22901979) Value Health. 2007 May-Jun;10(3):183-94. (PMID: 17532811) Obstet Gynecol. 2019 Dec;134(6):1234-1244. (PMID: 31764734) Blood Coagul Fibrinolysis. 2014 Jul;25(5):471-5. (PMID: 24509327) Haemophilia. 2021 Feb;27 Suppl 3:75-81. (PMID: 32985086) Expert Rev Hematol. 2023 Mar;16(sup1):107-127. (PMID: 36920855) Expert Rev Hematol. 2023 Mar;16(sup1):19-37. (PMID: 36920859) Haemophilia. 2021 Mar;27(2):293-304. (PMID: 33368856) Expert Rev Hematol. 2023 Mar;16(sup1):129-134. (PMID: 36920857) Hematology Am Soc Hematol Educ Program. 2006;:474-85. (PMID: 17124102) Expert Rev Hematol. 2023 Mar;16(sup1):1-5. (PMID: 36920858) Pediatrics. 2006 Nov;118(5):2245-50. (PMID: 17079600) Haemophilia. 2022 Sep;28(5):760-768. (PMID: 35700441) Anaesthesia. 2015 Jan;70 Suppl 1:78-86, e27-8. (PMID: 25440400) Am J Hematol. 2021 Apr 1;96(4):E105-E108. (PMID: 33428781) J Pediatr. 2022 Jan;240:171-176. (PMID: 34517012) Haemophilia. 2014 Nov;20(6):e426-9. (PMID: 25251752) Haemophilia. 2021 Nov;27(6):1045-1050. (PMID: 34587351) Expert Rev Hematol. 2023 Mar;16(sup1):7-11. (PMID: 36920861) Obstet Gynecol Surv. 1980 Oct;35(10):597-618. (PMID: 6997784) Expert Rev Hematol. 2023 Mar;16(sup1):39-54. (PMID: 36920856) J Womens Health (Larchmt). 2020 Jun;29(6):858-864. (PMID: 31971851) Obstet Gynecol. 2019 Sep;134(3):e71-e83. (PMID: 31441825) Expert Rev Hematol. 2023 Mar;16(sup1):55-70. (PMID: 36920862) Contraception. 2003 Mar;67(3):173-85. (PMID: 12618251) J Thromb Haemost. 2007 Jun;5(6):1165-9. (PMID: 17403089) Haemophilia. 2000 Nov;6(6):643-8. (PMID: 11122390) Haemophilia. 2004 Mar;10(2):158-61. (PMID: 14962204) J Womens Health (Larchmt). 2022 Mar;31(3):301-309. (PMID: 35275742) J Clin Med. 2022 Jul 30;11(15):. (PMID: 35956060) J Thromb Haemost. 2020 Dec;18(12):3211-3221. (PMID: 32979008) Scand J Clin Lab Invest. 1964;16:244-8. (PMID: 14161862) Haemophilia. 2018 Jan;24(1):63-69. (PMID: 28873279) EClinicalMedicine. 2021 Jan 29;32:100726. (PMID: 33554093) Eur J Haematol. 2015 Dec;95 Suppl 81:2-10. (PMID: 26679392) Expert Rev Hematol. 2020 Apr;13(4):313-321. (PMID: 32186928) Haemophilia. 1998 Nov;4(6):836-41. (PMID: 10028306) Res Pract Thromb Haemost. 2020 Dec 13;5(1):51-54. (PMID: 33537529) Res Pract Thromb Haemost. 2021 May 04;5(4):e12513. (PMID: 33977212) J Thromb Haemost. 2021 Jun;19(6):1506-1514. (PMID: 33774912) Haemophilia. 1999 Sep;5(5):313-7. (PMID: 10583512) J Pediatr Adolesc Gynecol. 2017 Jun;30(3):335-340. (PMID: 28108214) J Thromb Haemost. 2021 Aug;19(8):1883-1887. (PMID: 34327828) Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):236-242. (PMID: 27913486) Nature. 2014 Jan 30;505(7485):612-3. (PMID: 24482835) Haemophilia. 2022 Sep;28(5):832-841. (PMID: 35665573) J Thromb Haemost. 2019 Nov;17(11):1790-1797. (PMID: 31465627) Eur J Med Res. 2013 Jun 21;18:17. (PMID: 23786677) Haemophilia. 2019 Jul;25(4):575-580. (PMID: 31329369) Haemophilia. 2015 Sep;21(5):e442-5. (PMID: 26189327) Am J Hematol. 2014 Aug;89(8):831-6. (PMID: 24838518) Int J Gynaecol Obstet. 2018 Dec;143(3):393-408. (PMID: 30198563) Haemophilia. 2011 Mar;17(2):237-45. (PMID: 21118331) Prim Care. 2018 Dec;45(4):643-657. (PMID: 30401347) J Womens Health (Larchmt). 2021 Jul;30(7):956-963. (PMID: 33232627) Lancet. 1998 Feb 14;351(9101):485-9. (PMID: 9482440) Contraception. 2012 Mar;85(3):246-52. (PMID: 22067765) Haemophilia. 2013 Sep;19(5):e276-81. (PMID: 23607927) Haemophilia. 2016 Mar;22(2):199-207. (PMID: 26822547) Haemophilia. 2003 May;9(3):292-7. (PMID: 12694520) Acta Obstet Gynecol Scand. 1966;45(3):320-51. (PMID: 5922481) Haemophilia. 2020 Jan;26(1):17-24. (PMID: 31724316) J Thromb Haemost. 2014 Nov;12(11):1935-9. (PMID: 25059285) J Blood Med. 2020 Jan 06;11:1-11. (PMID: 32021526) BMC Womens Health. 2020 Feb 10;20(1):24. (PMID: 32041594) Blood Adv. 2021 Jan 12;5(1):280-300. (PMID: 33570651) Haemophilia. 2022 Mar;28(2):197-214. (PMID: 35040234) Haemophilia. 2011 Jan;17(1):e223-9. (PMID: 21040234) Thromb Haemost. 2002 Jun;87(6):1082-3. (PMID: 12083494) Am J Obstet Gynecol. 2020 Nov;223(5):624-664. (PMID: 32707266) PLoS One. 2020 Feb 20;15(2):e0229099. (PMID: 32078655) Am J Hematol. 2020 Jan;95(1):10-17. (PMID: 31612544) Int J Mol Sci. 2019 Jun 25;20(12):. (PMID: 31242705) Haemophilia. 2022 May;28 Suppl 4:53-60. (PMID: 35521733) BMC Womens Health. 2018 Aug 22;18(1):142. (PMID: 30134884) |
| معلومات مُعتمدة: | K12 HD085809 United States HD NICHD NIH HHS; K23 HL141640 United States HL NHLBI NIH HHS; R13 HL158209 United States HL NHLBI NIH HHS |
| فهرسة مساهمة: | Keywords: Gender disparity; National Hemophilia Foundation; Patient-centered; heavy menstrual bleeding; inherited bleeding disorders; sex disparity Local Abstract: [plain-language-summary] Up to 1% of cisgender women and girls have an inherited bleeding disorder (BD). Common symptoms include heavy menstrual bleeding (HMB), heavy bleeding after giving birth known as post-partum hemorrhage (PPH), nose bleeds, bleeding from the mouth, and excessive bleeding after surgery or procedures. They can also experience bleeding into their muscles, joints, and even into the brain. Uterine bleeding, such as from HMB and PPH, can impact the lives of anyone who has or had a uterus, a group we designate as people who have or had the potential to menstruate (PPM).Many PPM with an inherited BD do not receive diagnosis, treatment, and care needed due to a lack of expertise among health care professionals and the public, misunderstanding, and bias. Uncertainty about “normal” versus “abnormal” bleeding can contribute to a lack of diagnosis, treatment, and care. Language, such as the label of “carrier,” can be a barrier to accessing treatment and care for PPM.People with inherited BDs, health care professionals with various expertise and focus, and researchers worked together to identify the research that would most improve the lives of PPM, in six focus areas where there are major gaps in knowledge and the lack of standards required for accurate diagnosis. |
| تواريخ الأحداث: | Date Created: 20230315 Date Completed: 20230324 Latest Revision: 20240302 |
| رمز التحديث: | 20240302 |
| مُعرف محوري في PubMed: | PMC10020871 |
| DOI: | 10.1080/17474086.2023.2175660 |
| PMID: | 36920864 |
| قاعدة البيانات: | MEDLINE |
PDF full text from Publisher | تدمد: | 1747-4094 |
|---|---|
| DOI: | 10.1080/17474086.2023.2175660 |